Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, if he will make an assessment of the effect of the National Institute for Health and Care Excellence's health technology appraisals on pancreatic cancer research.
We have made no such assessment.
The National Institute for Health Research is investing £6.5 million over five years to 2017 in the Liverpool Pancreas Biomedical Research Unit. This unit is working in partnership with industry and leading research institutions to develop new treatments and diagnostic strategies for pancreatic cancer, so advancements in science can lead to benefits for patients.